Search
for
Sort by
Research 31–60 of 1000+
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Drug pipeline 2Q22 — a downturn in approvals
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Update on Efficacy of Generic Finasteride
- Bimatoprost in the treatment of eyelash hypotrichosis
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- 43696 Early real-world experience with baricitinib in the treatment of severe alopecia areata
- DRUG NEWS
- Pediatric Systemic Lupus Erythematosus
- An Analysis on Whether or Not Baldness Can Be Reversed
- Notes from the Editor Emeritus
- Index of the human papillomavirus (HPV) vaccine industry clinical study programmes and non-industry funded studies: a necessary basis to address reporting bias in a systematic review
- Coming full circle (almost): Low dose oral minoxidil for alopecia
- Alopecia – New building blocks
- The Triumph of JAK Inhibitors for the Treatment of Alopecia Areata
- 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study
- Deuruxolitinib for Alopecia Areata.
- Dutasteride for the Treatment of Androgenetic Alopecia: An Updated Review
- Editorial Comment
- Lipolytic agents for submental fat reduction: Review
- Pediatric Systemic Lupus Erythematosus: More Than a Positive Antinuclear Antibody
- Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor
- Exosomes in Dermatology.
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Efficacy and Safety of Spironolactone in Acne Management
- Exosomes in Facial Plastic Surgery
- Patient Profile and Treatment Characteristics of Early Ritlecitinib Initiators in the US